Factors Associated Within-Hospital Mortality in Mycosis Fungoides Patients: A Multivariable Analysis

被引:2
作者
King, Amber Loren O. [1 ]
Lee, Victor [2 ]
Mirza, Fatima N. [3 ]
Jairam, Vikram [2 ]
Yang, Daniel X. [2 ]
Yu, James B. [4 ]
Park, Henry S. [2 ]
Girardi, Michael [1 ]
Wilson, Lynn D. [2 ]
An, Yi [2 ]
机构
[1] Yale Sch Med, Dept Dermatol, New Haven, CT 06510 USA
[2] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT USA
[3] Brown Univ, Dept Dermatol, Providence, RI 02912 USA
[4] Columbia Univ, Dept Therapeut Radiol, New York, NY USA
关键词
mortality; sepsis; sezary syndrome; neds; cutaneous t-cell lymphoma; ctcl; mycosis fungoides; T-CELL LYMPHOMA; PROGNOSTIC-FACTORS; SEZARY-SYNDROME; ROMIDEPSIN; PATTERNS; RISK; CARE;
D O I
10.7759/cureus.28043
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Mycosis fungoides (MF) is the most common form of cutaneous T-cell lymphoma (CTCL). Although it often has an indolent course, it can progress to more aggressive CTCL forms. There is sparse data in current literature describing specific clinical factors associated with in-hospital mortality in mycosis fungoides patients. An understanding of patients at greatest risk for in-hospital mortality can aid in developing recommendations for prophylaxis and empirical management. Aim We aim to characterize factors associated with in-hospital mortality in MF patients. Materials and methods The Nationwide Emergency Department Sample (NEDS) was queried for MF cases from 2006 to 2015. Baseline demographic and hospital characteristics were stratified based on survival outcomes. Multivariable logistic regression was used to identify factors associated with in-hospital mortality. Results A total of 57,665 patients with MF presenting to the ED between 2006 and 2015 were identified. Skary syndrome, sepsis, and advanced age were associated with MF in-hospital mortality, while female sex was inversely associated. There was a downtrend in in-hospital mortality among MF patients presenting to the ED from 2006 to 2015. Conclusions Our study highlights factors crucial for risk-stratification for hospitalized MF patients.
引用
收藏
页数:7
相关论文
共 25 条
[1]   Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL) [J].
Allen, Pamela B. ;
Switchenko, Jeffrey ;
Ayers, Amy ;
Kim, Esther ;
Lechowicz, Mary Jo .
LEUKEMIA & LYMPHOMA, 2020, 61 (11) :2652-2658
[2]   Bexarotene is effective and safe for treatment of refractory advanced-stage cutaneous T-cell lymphoma: Multinational phase II-III trial results [J].
Duvic, M ;
Hymes, K ;
Heald, P ;
Breneman, D ;
Martin, AG ;
Myskowski, P ;
Crowley, C ;
Yocum, RC .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) :2456-2471
[3]   Efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma [J].
Duvic, Madeleine ;
Martin, Ann G. ;
Olsen, Elise A. ;
Fivenson, David P. ;
Prince, H. Miles .
LEUKEMIA & LYMPHOMA, 2013, 54 (03) :514-519
[4]   Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity [J].
Huang, Jennifer T. ;
Abrams, Melissa ;
Tlougan, Brook ;
Rademaker, Alfred ;
Paller, Amy S. .
PEDIATRICS, 2009, 123 (05) :E808-E814
[5]   The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients [J].
Kelly-Sell, Michael J. ;
Kim, Youn H. ;
Straus, Suzanne ;
Benoit, Bernice ;
Harrison, Cameron ;
Sutherland, Katherine ;
Armstrong, Randall ;
Weng, Wen-Kai ;
Showe, Louise C. ;
Wysocka, Maria ;
Rook, Alain H. .
AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (04) :354-360
[6]   Immunopathogenesis and therapy of cutaneous T cell lymphoma [J].
Kim, EJ ;
Hess, S ;
Richardson, SK ;
Newton, S ;
Showe, LC ;
Benoit, BM ;
Ubriani, R ;
Vittorio, CC ;
Junkins-Hopkins, JM ;
Wysocka, M ;
Rook, AH .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :798-812
[7]   Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression [J].
Kim, YH ;
Liu, HL ;
Mraz-Gernhard, S ;
Varghese, A ;
Hoppe, RT .
ARCHIVES OF DERMATOLOGY, 2003, 139 (07) :857-866
[8]   Changing Incidence Trends of Cutaneous T-Cell Lymphoma [J].
Korgavkar, Kaveri ;
Xiong, Michael ;
Weinstock, Martin .
JAMA DERMATOLOGY, 2013, 149 (11) :1295-1299
[9]   Early-stage Mycosis Fungoides: Epidemiology and Prognosis [J].
Maguire, Andrew ;
Puelles, Jorge ;
Raboisson, Patrick ;
Chavda, Rajeev ;
Gabriel, Sylvie ;
Thornton, Susan .
ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
[10]   Romidepsin for the treatment of T-cell lymphomas [J].
McGraw, Angie L. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (13) :1115-1122